|
ATG12 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.66209999999234E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.6887000000081E-05 |
| Normal-vs-Stage2 |
2.23609999999708E-05 |
| Normal-vs-Stage3 |
7.67329999999955E-05 |
| Normal-vs-Stage4 |
8.987900E-04 |
| Stage1-vs-Stage2 |
1.172430E-01 |
| Stage1-vs-Stage3 |
5.397800E-01 |
| Stage1-vs-Stage4 |
5.765000E-01 |
| Stage2-vs-Stage3 |
2.688000E-01 |
| Stage2-vs-Stage4 |
4.205400E-01 |
| Stage3-vs-Stage4 |
9.164400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.372050E-04 |
| Normal-vs-AfricanAmerican |
3.238400E-01 |
| Normal-vs-Asian |
6.24599999999864E-05 |
| Caucasian-vs-AfricanAmerican |
8.474400E-02 |
| Caucasian-vs-Asian |
3.579400E-01 |
| AfricanAmerican-vs-Asian |
2.339800E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.617100E-04 |
| Normal-vs-Female |
4.26030000000299E-05 |
| Male-vs-Female |
5.790400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.279980E-03 |
| Normal-vs-Age(41-60Yrs) |
4.14939999999753E-05 |
| Normal-vs-Age(61-80Yrs) |
4.31690000002316E-06 |
| Normal-vs-Age(81-100Yrs) |
1.630180E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.176840E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.814300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.952800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.581400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.188000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.612800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.530000E-01 |
| Classical-VS-Follicular |
2.431800E-02 |
| Classical-VS-Other |
6.011200E-01 |
| Classical-VS-Normal |
1.016080E-03 |
| Tall-VS-Follicular |
2.600600E-01 |
| Tall-VS-Other |
8.084200E-01 |
| Tall-VS-Normal |
2.740600E-03 |
| Follicular-VS-Other |
7.670000E-01 |
| Follicular-VS-Normal |
1.7585299999956E-05 |
| Other-VS-Normal |
5.972000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.86880000036172E-07 |
| Normal-vs-N1 |
8.858000E-03 |
| N0-vs-N1 |
1.303220E-01 |
|
|
